Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy.

Chavez-Tapia NC, Cesar-Arce A, Barrientos-Gutiérrez T, Villegas-López FA, Méndez-Sanchez N, Uribe M.

Nutr J. 2013 Jun 6;12:74. doi: 10.1186/1475-2891-12-74. Review.

2.

Branched-chain amino acids for people with hepatic encephalopathy.

Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H.

Cochrane Database Syst Rev. 2015 Feb 25;(2):CD001939. doi: 10.1002/14651858.CD001939.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(9):CD001939.

PMID:
25715177
3.

Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Gluud LL, Vilstrup H, Morgan MY.

Cochrane Database Syst Rev. 2016 May 6;(5):CD003044. doi: 10.1002/14651858.CD003044.pub4. Review.

PMID:
27153247
4.

Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Gluud LL, Vilstrup H, Morgan MY.

Cochrane Database Syst Rev. 2016 Apr 18;4:CD003044. doi: 10.1002/14651858.CD003044.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD003044.

PMID:
27089005
5.

Nutritional support for liver disease.

Koretz RL, Avenell A, Lipman TO.

Cochrane Database Syst Rev. 2012 May 16;(5):CD008344. doi: 10.1002/14651858.CD008344.pub2. Review.

PMID:
22592729
6.

Zinc supplementation for tinnitus.

Person OC, Puga ME, da Silva EM, Torloni MR.

Cochrane Database Syst Rev. 2016 Nov 23;11:CD009832. Review.

PMID:
27879981
7.

Nonabsorbable disaccharides for hepatic encephalopathy.

Als-Nielsen B, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2004;(2):CD003044. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD003044.

PMID:
15106187
8.

Dopamine agents for hepatic encephalopathy.

Junker AE, Als-Nielsen B, Gluud C, Gluud LL.

Cochrane Database Syst Rev. 2014 Feb 10;(2):CD003047. doi: 10.1002/14651858.CD003047.pub3. Review.

PMID:
24515383
9.

Ursodeoxycholic acid for primary biliary cirrhosis.

Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD000551. doi: 10.1002/14651858.CD000551.pub3. Review.

PMID:
23235576
10.

Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial.

Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G, Ziparo V, Pedretti G, Fiaccadori F, Bottari E, et al.

Dig Dis Sci. 1991 Sep;36(9):1204-8.

PMID:
1893805
11.

Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age.

Mayo-Wilson E, Junior JA, Imdad A, Dean S, Chan XH, Chan ES, Jaswal A, Bhutta ZA.

Cochrane Database Syst Rev. 2014 May 15;(5):CD009384. doi: 10.1002/14651858.CD009384.pub2. Review.

PMID:
24826920
12.

Dopaminergic agonists for hepatic encephalopathy.

Als-Nielsen B, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003047. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD003047.

PMID:
15495041
13.

Nitazoxanide for chronic hepatitis C.

Nikolova K, Gluud C, Grevstad B, Jakobsen JC.

Cochrane Database Syst Rev. 2014 Apr 6;(4):CD009182. doi: 10.1002/14651858.CD009182.pub2. Review.

PMID:
24706397
14.

Is immediate imaging important in managing low back pain?

Andersen JC.

J Athl Train. 2011 Jan-Feb;46(1):99-102. doi: 10.4085/1062-6050-46.1.99.

15.

Branched-chain amino acids for hepatic encephalopathy.

Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C.

Cochrane Database Syst Rev. 2003;(2):CD001939. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD001939.

PMID:
12804416
16.

l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.

Bai M, Yang Z, Qi X, Fan D, Han G.

J Gastroenterol Hepatol. 2013 May;28(5):783-92. doi: 10.1111/jgh.12142.

PMID:
23425108
17.

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.

Luo M, Li L, Lu CZ, Cao WK.

Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1250-7. doi: 10.1097/MEG.0b013e32834d1938.

PMID:
21971378
18.

Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy.

Holte K, Krag A, Gluud LL.

Hepatol Res. 2012 Oct;42(10):1008-15. doi: 10.1111/j.1872-034X.2012.01015.x. Epub 2012 Apr 30.

PMID:
22548675
19.

Aminoadamantanes for chronic hepatitis C.

Lamers MH, Broekman M, Drenth JP, Gluud C.

Cochrane Database Syst Rev. 2014 May 3;(5):CD010125. doi: 10.1002/14651858.CD010125.pub2. Review.

PMID:
24793264
20.

Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial.

Reding P, Duchateau J, Bataille C.

Lancet. 1984 Sep 1;2(8401):493-5.

PMID:
6147551

Supplemental Content

Support Center